List of Excipients in API tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate
Detailed excipient profiles for tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate
Excipient focus: CYSTEINE HYDROCHLORIDE
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants containing CYSTEINE HYDROCHLORIDE
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants not containing CYSTEINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants containing MANNITOL
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: STANNOUS CHLORIDE
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants containing STANNOUS CHLORIDE
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants not containing STANNOUS CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants containing TRISODIUM CITRATE DIHYDRATE
tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
